NantBio

Culver City, United States

NantBio offers treatments by developing molecularly targeted drugs, based on the molecular profile of the patient’s tumor.

$2.0M raised

Feb 2024

Venture - Series Unknown

30,000+ verified contacts

Emails, phones & LinkedIn profiles

Frequently Asked Questions about NantBio

How much funding has NantBio raised?

NantBio has raised $2.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in February 2024.

Where is NantBio headquartered?

NantBio is headquartered in Culver City, United States.

What does NantBio do?

NantBio offers treatments by developing molecularly targeted drugs, based on the molecular profile of the patient’s tumor.

What stage is NantBio at?

NantBio is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 9, 2024.

MLA

"NantBio — Funding & Investors." VCBacked, February 9, 2024, https://www.vcbacked.co/company/nantbio. Accessed July 2, 2026.

APA

VCBacked. (2024). NantBio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/nantbio

Wikipedia (cite web)

{{cite web |title=NantBio — Funding & Investors |url=https://www.vcbacked.co/company/nantbio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 9, 2024.